로딩 중…
지수 로딩 중…
Prothena Corporation plc
PRTA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
IE
IE$8.93+5.18%
2026-06-18
Price Chart
Prothena Corporation plc+55.30%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $468M |
| Revenue | $58M |
| Net Income | $-151M |
| Total Assets | $350M |
| Net Assets | $313M |
| Value | |
| P/B | 1.50x |
| P/S | 8.07x |
| FCF Yield | -17.42% |
| Profitability | |
| ROE | -48.36% |
| ROA | -43.21% |
| Op. Margin | -217.94% |
| Revenue Growth | 1706.36% |
| Financial Health | |
| Debt Ratio | 11.92% |
| Total Debt | $8M |
| FCF | $-81M |
| Cash | $329M |
| Current Ratio | 10.43x |
| Performance | |
| 1Y Return | 55.30% |
| 1M Return | -1.54% |
| From 52W High | -24.32% |
| 1Y MDD | -55.20% |
| Trading | |
| Volume | 1,134,646 shares |
| Trading Value | $10M |
| Per Share | |
| EPS | $-4.53 |
| BPS | $5.21 |